| Contrast sensitivity function in patients with beta-thalassemia major. | |
| | |
MedLine Citation:
|
PMID: 11037904 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To investigate contrast sensitivity function in patients with beta-thalassemia major, after regular transfusion and chelation therapy. METHODS: We measured contrast sensitivity at four spatial frequencies in 30 patients with beta-thalassemia major and in 30 matched normal control subjects. All subjects underwent an ophthalmic examination that included fluorescein angiography. The contrast sensitivity results from the two groups were compared between them. Patients' contrast sensitivity values were correlated to the variables age, duration of transfusion, duration of chelation therapy and serum ferritin levels, to select the important predictors. RESULTS: Contrast sensitivity function in all beta-thalassemic patients was significantly lower (p<0.0001) compared to the normal control subjects, for all spatial frequencies tested. The most important predictor of contrast sensitivity loss was patients' age. CONCLUSION: Contrast sensitivity testing can detect early changes in the visual function of beta-thalassemic patients and should be considered as a monitor for patients under chronic transfusion-chelation therapy. |
| | |
Authors:
|
S P Gartaganis; N Zoumbos; J X Koliopoulos; E K Mela |
Related Documents
:
|
9293854 - Incidence of endocrine complications and clinical disease severity related to genotype ... 11550164 - Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the respo... 12749014 - Role of phlebotomy in the management of hemoglobin sc disease: case report and review o... 155504 - Glycolysis measurements in red cells from drug-treated epileptic and anaemia patients. 20470274 - Statins for prevention of contrast-induced nephropathy in patients undergoing non-emerg... 2316094 - Analysis of voiding disorders in patients with cerebrovascular accidents. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta ophthalmologica Scandinavica Volume: 78 ISSN: 1395-3907 ISO Abbreviation: Acta Ophthalmol Scand Publication Date: 2000 Oct |
Date Detail:
|
Created Date: 2001-01-11 Completed Date: 2001-01-25 Revised Date: 2008-03-17 |
Medline Journal Info:
|
Nlm Unique ID: 9507578 Medline TA: Acta Ophthalmol Scand Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 512-5 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology, University of Patras Medical School, Greece. ifigenia@hol.gr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Blood Transfusion Chelation Therapy Contrast Sensitivity / physiology* Deferoxamine / therapeutic use Female Ferritins / blood Fluorescein Angiography Humans Male Middle Aged Vision Disorders / physiopathology beta-Thalassemia / blood, physiopathology*, therapy |
| Chemical | |
Reg. No./Substance:
|
70-51-9/Deferoxamine; 9007-73-2/Ferritins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Colour contrast sensitivity in cataract and pseudophakia.
Next Document: The effect of phenylephrine on pain and flare intensity in eyes with uveitis.